chevron_left
Is the EU Biotech Act Europe’s innovation turning point?
Speakers
Is the sector stabilizing or structurally shifting? Join global experts to unpack the dealmaking trends defining the next cycle of innovation.
In this on demand session, industry experts explore the EU Biotech Act from a practical, real-world perspective, examining how it aligns with other European innovation initiatives and what it could mean for organizations operating in Europe’s biotech and life sciences ecosystem.
In this session, you’ll explore:
- The current state of Europe’s R&D and biotech landscape amid intensifying global competition
- Key regulatory interventions proposed under the EU Biotech Act, and their potential implications
- Industry perspectives on the modernization of Europe’s regulatory framework
- The evolving role of Joint Clinical Assessments (JCAs) and Joint Scientific Consultations (JSCs) and their anticipated impact on innovation and evidence generation
Explore how global regulatory intelligence across the product lifecycle supports informed regulatory decision making.
